Sign Up
OverviewAPI
Australian shares fell as biotech firm CSL Ltd's cardiovascular drug trial failed, leading to a 6.2% intraday drop. Other healthcare firms, such as Cochlear Ltd and Resmed Inc, also declined. Market participants await the U.S. CPI inflation data, which could impact the Federal Reserve's interest rate decision. Miners and energy companies experienced losses, while the financials sector saw a marginal increase.

Ask a question